The Adult Therapeutics Handbook content has now been updated. This update includes; An update to some of the COVID-19 guidelines:
Therapeutics Handbook Update: 1 May 2020
Posted: Friday, May 1, 2020
Category - Medicines Update
Posted: Friday, May 1, 2020
Category - Medicines Update
The Adult Therapeutics Handbook content has now been updated. This update includes; An update to some of the COVID-19 guidelines:
Posted: Wednesday, April 29, 2020
Category - Medicines Update
Interim NHSGGC Medicines Governance Processes During the COVID-19 Pandemic In light of the COVID-19 pandemic, the NHSGGC Area Drug and Therapeutics Committee (ADTC) and its subcommittees, has cancelled its meetings for ...
Posted: Friday, April 24, 2020
Category - Medicines Update
NHS GGC Thromboprophylaxis Guidelines for COVID-19 patients are now available.
Posted: Wednesday, April 22, 2020
Category - Medicines Update
Esmya (ulipristal acetate): suspension of the licence due to ri...
Posted: Wednesday, April 22, 2020
Category - Medicines Update
NHS GGC Guidance: Conversion from warfarin to a direct oral anticoagulant (DOAC) during hospital admission for patients with non-valvular atrial fibrillation* (AF) or venous thromboembolism (VTE) * non-valvular AF exclu...
Posted: Wednesday, April 22, 2020
Category - Medicines Update
Key messages: Following a review, the Commission on Human Medicines’ Expert Working Group on coronavirus (COVID-19) concluded that there is currently insufficient evidence to establish a link between use of...
Posted: Wednesday, April 22, 2020
Category - Medicines Update
COVID-19 NHSGGC Guidelines relating to medicines published between 13th and 17th April New Adult NHSGGC Guidelines now available on StaffNet
Posted: Friday, April 10, 2020
Category - Medicines Update
The Adult Therapeutics Handbook content has now been updated. This update includes the publication of two new guidelines related to the COVID pandemic in the following section.
Posted: Wednesday, April 8, 2020
Category - Medicines Update
Posted: Monday, March 30, 2020
Category - Medicines Update
Key point Denosumab treatment for osteoporosis should continue during the current COVID-19 pandemic Please refer to the following statement from the NHSGGC Osteoporosis Strategy Group: ...